Clinical Trial Update: Efficacy Study of Pembrolizumab With Entinostat to Treat Metastatic Melanoma of the Eye [Phase 2]

View source ↗

Summary

Phase 2 trial examining pembrolizumab with entinostat for metastatic uveal melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Drugs mentioned

• Entinostat (entinostat)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Vastra Gotaland Region | Conditions: Metastatic Uveal Melanoma | Phase 2 | Status: COMPLETED